The benefit-risk politics of vaccination against hepatitis B virus
Degos, F.
Italian Journal of Gastroenterology and Hepatology 31(5): 392-394
1999
ISSN/ISBN: 1125-8055 PMID: 10470599 Document Number: 506053
Document emailed within 1 workday
Related Documents
Gutersohn, T.; Steffen, R.; Van Damme, P.; Holdener, F.; Beutels, P. 1996: Hepatitis A infection in aircrews: risk of infection and cost-benefit analysis of hepatitis A vaccination Aviation Space and Environmental Medicine 67(2): 153-156Jönsson, B. 1987: Cost-benefit analysis of hepatitis B vaccination Postgraduate Medical Journal 63(Suppl 2): 27-32
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Rivera, F.; Lissen, E.; Vázquez, R.; Arroyo, F.; Sánchez-Quijano, A.; García de Pesquera, F.; Leal, M.; Lozano, F.; Cordero, A.; Herrera, C. 1984: Cost-benefit analysis of a program for vaccination against hepatitis B in health personnel of a hospital Medicina Clinica 83(15): 611-614
Langat, B.; Muge, E.K.; Night, D.; Okoth, F.; Ochwedo, K.O.; Songok, E.M. 2023: Sero-prevalence of hepatitis B virus and compliance with hepatitis B vaccination schedules among outpatient clinic attendees in Nairobi PLOS one 18(2): E0281256
Mao, B.; Patel, M.K.; Hennessey, K.; Duncan, R.J.W.; Wannemuehler, K.; Soeung, S.Chan. 2013: Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia Vaccine 31(40): 4459-4464
Zhang, S.X. 1992: Chinese strategies for hepatitis B virus markers screening in hepatitis B vaccination based on cost-effectiveness analysis Zhonghua Yu Fang Yi Xue Za Zhi 26(3): 154-158
Stark, K.; Meyer, C.G.; Tacke, M.; Schwarz, A.; Braun, C.; Huzly, D.; Engel, A.M.; May, J.; Bienzle, U. 1997: Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors Transplantation 64(4): 608-612
Ioniţă, E.; Lupulescu, E.; Alexandrescu, V.; Chiriţă, C.; Bălteanu, M.; Neguţ, A.E. 1995: False-positive ELISA reactions for the hepatitis C virus and the human immunodeficiency virus after anti-influenzal vaccination Bacteriologia Virusologia Parazitologia Epidemiologia 40(3-4): 249-252
Saves, M.; Raffi, F.; Clevenbergh, P.; Marchou, B.; Waldner-Combernoux, A.; Morlat, P.; LeMoing, V.; Riviere, C.; Chene, G.; Leport, C.; The APROCOStudy Group, 2000: Hepatitis B or Hepatitis C Virus Infection Is a Risk Factor for Severe Hepatic Cytolysis after Initiation of a Protease Inhibitor-Containing Antiretroviral Regimen in Human Immunodeficiency Virus-Infected Patients Antimicrobial Agents and Chemotherapy 44(12): 3451-3455
Oliveira, S.A.N.; Hacker, M.A.; Oliveira, M.L.A.; Yoshida, C.F.T.; Telles, P.R.; Bastos, F.I. 2005: A window of opportunity: declining rates of hepatitis B virus infection among injection drug users in Rio de Janeiro, and prospects for targeted hepatitis B vaccination Revista Panamericana de Salud Publica 18(4-5): 271-277
Hudecková, H.; Straka, S.; Szilágyiová, M.; Avdicová, M.; Rusnáková, S. 2002: Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic Central European Journal of Public Health 10(4): 146-148
Buster, E.H.J.C.; de Man, R.A. 2014: Vaccination is not always sufficient to prevent vertical transmission of hepatitis B virus Nederlands Tijdschrift Voor Geneeskunde 158: A8151
Magdzik, W.ła.; Zieliński, A. 2005: Vaccination against hepatitis B and the risk of multiple sclerosis Przeglad Epidemiologiczny 59(1): 11-19
Nesic, Z.; Delic, D.; Prostran, M.; Vuckovic, S.; Stojanovic, R. 2002: Hepatitis G virus infection in individuals at high risk of transmission of viral hepatitis International Journal of Antimicrobial Agents 19(Suppl 1): S39
Techasathit, W.; Ratanasuwan, W.; Sonjai, A.; Sangsiriwut, K.; Anekthananon, T.; Suwanagool, S. 2005: Vaccination against hepatitis B virus: are Thai medical students sufficiently protected? Journal of the Medical Association of Thailand 88(3): 329-334
Celen, M.K.; Ayaz, C.; Hosoglu, S.; Geyik, M.F.; Ulug, M. 2006: Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey Saudi Medical Journal 27(5): 617-620